Open Access
| Issue |
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
|
|
|---|---|---|
| Article Number | 02026 | |
| Number of page(s) | 6 | |
| Section | Biomedical Advances and Personalized Medicine | |
| DOI | https://doi.org/10.1051/bioconf/202411102026 | |
| Published online | 31 May 2024 | |
- Gaddam, S., et al., Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018. Jama, 2021. 326(20): p. 2075–2077. [CrossRef] [PubMed] [Google Scholar]
- Ferlay, J., et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015. 136(5): p. E359–86. [CrossRef] [PubMed] [Google Scholar]
- Hidalgo, M., et al., Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology, 2015. 15(1): p. 8–18. [CrossRef] [PubMed] [Google Scholar]
- Vincent, A., et al., Pancreatic cancer. Lancet, 2011. 378(9791): p. 607–20. [CrossRef] [PubMed] [Google Scholar]
- Ou, A., X. Zhao, and Z. Lu, The potential roles of p53 signaling reactivation in pancreatic cancer therapy. Biochim Biophys Acta Rev Cancer, 2022. 1877(1): p. 188662. [CrossRef] [PubMed] [Google Scholar]
- Klein, A.P., Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol, 2021. 18(7): p. 493–502. [CrossRef] [PubMed] [Google Scholar]
- He, J., et al., 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford), 2014. 16(1): p. 83–90. [Google Scholar]
- Jalil, A.T., et al., Peptide-Based Therapeutics in Cancer Therapy. Mol Biotechnol, 2023. [PubMed] [Google Scholar]
- Watanabe, K., et al., Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight, 2018. 3(7). [PubMed] [Google Scholar]
- Wood, L.D., et al., Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment. Gastroenterology, 2022. 163(2): p. 386–402.e1. [CrossRef] [PubMed] [Google Scholar]
- Kolbeinsson, H.M., et al., Pancreatic Cancer: A Review of Current Treatment and Novel Therapies. J Invest Surg, 2023. 36(1): p. 2129884. [CrossRef] [PubMed] [Google Scholar]
- He, Q., Z. Liu, and J. Wang, Targeting KRAS in PDAC: A New Way to Cure It? Cancers (Basel), 2022. 14(20). [Google Scholar]
- Quatannens, D., et al., Targeting hedgehog signaling in pancreatic ductal adenocarcinoma. Pharmacol Ther, 2022. 236: p. 108107. [CrossRef] [PubMed] [Google Scholar]
- Waddell, N., et al., Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 2015. 518(7540): p. 495–501. [CrossRef] [PubMed] [Google Scholar]
- Miglio, U., et al., KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance. Pathol Res Pract, 2014. 210(5): p. 307–11. [CrossRef] [PubMed] [Google Scholar]
- Hanada, K., et al., Endoscopic approach in the diagnosis of high-grade pancreatic intraepithelial neoplasia. Dig Endosc, 2022. 34(5): p. 927–937. [CrossRef] [PubMed] [Google Scholar]
- McCubrey, J.A., et al., Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression. Cells, 2022. 11(14). [Google Scholar]
- Fakhri, B. and K.H. Lim, Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature. J Gastrointest Oncol, 2017. 8(3): p. 379–386. [CrossRef] [PubMed] [Google Scholar]
- Wood, L.D. and R.H. Hruban, Genomic landscapes of pancreatic neoplasia. J Pathol Transl Med, 2015. 49(1): p. 13–22. [CrossRef] [PubMed] [Google Scholar]
- Hosein, A.N., R.A. Brekken, and A. Maitra, Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol, 2020. 17(8): p. 487–505. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.